Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice
Federica Maione(Candiolo Cancer Institute), Enrico Giraudo(University of California, San Francisco), Guido Serini(Candiolo Cancer Institute), Oriol Casanovas(Institut Català d'Oncologia), Federico Bussolino(Candiolo Cancer Institute), Lorena Zentilin(National Center for Genetic Engineering and Biotechnology), Donatella Regano(Candiolo Cancer Institute), Stefania Capano(University of Turin), Mauro Giacca(King's College London)
Cited by 184
Related Papers
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
|Cancer Cell|2009|2.3k
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
|Cancer Cell|2005|1.6k
Internalization of HIV-1 Tat Requires Cell Surface Heparan Sulfate Proteoglycans
|Journal of Biological Chemistry|2001|713
An amino-bisphosphonate targets MMP-9–expressing macrophages and angiogenesis to impair cervical carcinogenesis
|Journal of Clinical Investigation|2004|609
An amino-bisphosphonate targets MMP-9–expressing macrophages and angiogenesis to impair cervical carcinogenesis
|Journal of Clinical Investigation|2004|576